- About MicuRx
- Scientific research
- Newsroom
-
Metabolism of MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative ring opening of 2,3-dihydropyridin-4-one catalyzed by non-P450 enzymes
Drug Metab Dispos / 2015View Publication
-
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile
J Med Chem / 2014View Publication
-
Selection and characterization of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I
Int J Antimicrob Agents / 2014View Publication
-
In vivo Antibacterial Activity of MRX-I, a New Oxazolidinone
Antimicrob Agents Chemother / 2014View Publication
- Scientific research
